RBR-7tdjcn5
Active, Not Recruiting
N/A
Efficacy and safety of using Botulinum Toxin type A in the Masseter Hypertrophy treatment
Faculdade Ingá - UNINGÁ/Paraná0 sitesJanuary 24, 2024
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Masseter muscle
- Sponsor
- Faculdade Ingá - UNINGÁ/Paraná
- Status
- Active, Not Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Female patients; age between 25 and 50 years; complaining of enlargement of the lower third of the face; complaining of unilateral or bilateral hypertrophy of the masseter muscle; have not received aesthetic procedures on the lower third of the face in the last 12 months
Exclusion Criteria
- •Having received an anti\-tetanus or COVID\-19 vaccine within a period of less than three months, before starting the research; having previously received injections of botulinum toxin for aesthetic or therapeutic purposes; presenting autoimmune diseases; pregnant and lactating women; present neuromuscular diseases (Myasthenia gravis and Lambert\-Eaton Syndrome); in current use of drugs that act on neuromuscular junctions; having performed cosmetic surgeries on the lower third of the face; missing teeth; individuals under 25 years of age; those who do not agree to sign the Free and Informed Consent Form; those who receive some type of vaccine during the research; received aesthetic procedures in the lower third of the face in the last 12 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
The efficacy and safety of botulinum toxin type B on digital ulcers in patients with systemic sclerosisdigital ulcers in systemic sclerosis patientsJPRN-UMIN000024818Gunma University Hospital10
Recruiting
N/A
The Effect and safety of Botox in the treatment of patients with Spinal injury associated with Human T-cell Lymphotrofic Virus type IRBR-67ynvtHospital Universitário Professor Edgard Santos
Completed
N/A
Effects of Botulinum Toxin Type A in patients with chronic orofacial paiTemporomandibular Joint Dysfunction SyndromeC05.500.607.221.897RBR-8fsspyyFaculdade de Odontologia de Bauru, Universidade de São Paulo
Active, Not Recruiting
N/A
EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON UPPER LIMB SPASTICITY IN INFLAMMATORY AND DEMIELINIZZATING DISEASE OF CENTRAL NERVOUS SYSTEM. - NDmultiple sclerosisMedDRA version: 9.1Level: HLTClassification code 10052785Term: Multiple sclerosis acute and progressiveEUCTR2007-006268-32-ITOSPEDALE S. RAFFAELE
Not Yet Recruiting
Phase 3
Comparison of the effect of combining botulinum toxin and cross-linked hyaluronic acid with non cross-linked hyaluronic acid in the treatment of icepick acne scarIRCT20210718051930N1Iran University of Medical Sciences16